Safety of Curcuma aromatica oil gelatin microspheres administered via hepatic artery

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 10, Issue 18

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

355

HTML

2458

Figures (1-3)

208

Tables (1-6)

185

Sum=3206

Sep 15, 2004 (publication date) through Nov 5, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Liver Cancer

World J Gastroenterol. Sep 15, 2004; 10(18): 2637-2642
Published online Sep 15, 2004. doi: 10.3748/wjg.v10.i18.2637

Table 1 Deaths of the rats after administration of CAO-GMS

Group	Number of rats	Dosage (mg/kg)	Number of dead rats	Mortality (%)	Peak time of death occurrence (h)
CAO-GMS-1	10	5	0	0	-
CAO-GMS-2	12	10	4	33.33	24-48
CAO-GMS-3	14	20	8	57.14	24-48
CAO-GMS-4	12	40	12	100	< 24
GMS	10	40	7	71.42	24-48
Blank control	8	3.5¹	0	0	-
CAO	8	3.2	0	0	-

¹Measured in mL/kg.

Citation: Deng SG, Wu ZF, Li WY, Yang ZG, Chang G, Meng FZ, Mo LL. Safety of Curcuma aromatica oil gelatin microspheres administered via hepatic artery. World J Gastroenterol 2004; 10(18): 2637-2642
URL: https://www.wjgnet.com/1007-9327/full/v10/i18/2637.htm
DOI: https://dx.doi.org/10.3748/wjg.v10.i18.2637